Skip to main content

UBS Group AG

Position in TPST — Tempest Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in TPST

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$7,433
-$42,911 QoQ
Shares Held
4,533
-74.2% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TPST Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $7,583,539,921 across 563 Biotechnology names. TPST ranks #452 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TPST

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,433 4,533
2025-12-31 $50,344 17,542
2025-09-30 $117,078 11,389
2025-06-30 $76,316 11,223
2025-03-31 $238,889 323,699
2024-12-31 $163,388 195,676
2024-09-30 $11,752 8,395
2024-03-31 $3,601 921
2023-12-31 $1,170 266
2023-06-30 $1,015 800
2022-09-30 $4,992 2,869
2022-06-30 $10,734 4,993
2021-09-30 $14,224 983
2021-06-30 $1,643 147